Author:
Takeuchi Esther S.,Leising Randolph A.
Abstract
AbstractLithium batteries have been successfully used in implantable biomedical devices for the last 30 years, and in some cases the use of lithium power sources has significantly contributed to the viability of the device. These battery systems fall into two major categories: primary, or single-use, cells containing lithium-metal anodes; and secondary, or rechargeable, systems utilizing lithium-ion chemistry. Primary lithium batteries have been used for implantable devices such as cardiac pacemakers, drug pumps, neurostimulators, and cardiac defibrillators. Rechargeable batteries have been used with left ventricular assist devices and total artificial hearts. All of these cells share the characteristics of high safety, reliability, energy density, and predictability of performance. Additionally, state-of-charge indication and low self-discharge are important features, along with charging safety and high cycle life for rechargeable cells.
Publisher
Springer Science and Business Media LLC
Subject
Physical and Theoretical Chemistry,Condensed Matter Physics,General Materials Science
Reference22 articles.
1. 17. Fehrmann G. , Frommel R. , and Wolf R. , U.S. Patent No. 5,587,258 (December 24, 1996).
2. The Reduction of Silver Vanadium Oxide in Lithium/Silver Vanadium Oxide Cells
3. Discharge reaction and overpotential of the graphite fluoride cathode in a nonaqueous lithium cell
4. 9. Greatbatch W. , Holmes C.F. , Takeuchi E.S. , and Ebel S.J. , “Lithium/Carbonmonofluoride (U/CF x ): A New Pacemaker Battery,” presented at Cardiostim '96, 10th Int. Congress on Cardiac Pacing and Electrophysiology and Cardiac Pacing, Nice, France, June 1996.
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献